Technology | Interventional Radiology | February 20, 2019

Flexible robotic catheter helps physicians reach nodules in the peripheral lung

FDA Clears Ion Endoluminal Lung Biopsy System

February 20, 2019 — The U.S. Food and Drug Administration (FDA) cleared the Ion endoluminal system from Intuitive Surgical Inc. to enable minimally invasive biopsy in the peripheral lung.

Lung cancer is the world’s leading cause of cancer deaths, according to Intuitive Surgical. Many suspicious lesions found in the lung may be small and difficult to access, which can make obtaining a diagnosis challenging.

The Ion system uses an ultra-thin articulating robotic catheter that can move 180 degrees in all directions. The outer diameter of the catheter is 3.5 mm, which physicians can navigate through small and tortuous airways to reach nodules in any airway segment within the lung. The system’s flexible biopsy needle (called the Flexision Biopsy Needle) can also pass through very tight bends via Ion’s catheter to collect tissue in the peripheral lung. The catheter’s 2mm working channel can also accommodate other biopsy tools, such as biopsy forceps or cytology brushes, if necessary.

Intuitive developed the system’s fiber optic shape sensor technology to provide the physician with the precise location and shape information of the catheter throughout the navigation and biopsy process. The system is designed to easily integrate into existing lung nodule biopsy workflows, as well as existing imaging technology, including fluoroscopy, radial-endobronchial ultrasound and cone-beam computed tomography (CBCT).

Intuitive plans to introduce the Ion system in the U.S. in a measured fashion, with customer shipments beginning in the second quarter of 2019.

For more information: www.intuitive.com

Related Content

News | Artificial Intelligence

November 28, 2021 — Riverain Technologies, a leader in artificial intelligence (AI) for early, efficient detection of ...

Time November 28, 2021
arrow
News | Lung Imaging

November 23, 2021 — Median Technologies announces new outstanding performance of its lung cancer screening (LCS) CADx1 ...

Time November 23, 2021
arrow
News | Interventional Radiology

November 23, 2021 — A minimally invasive ablation procedure offers long-term relief for patients who experience chronic ...

Time November 23, 2021
arrow
News | Artificial Intelligence

November 22, 2021 — Sirona Medical, a software company founded on a deep understanding of both the practice and business ...

Time November 22, 2021
arrow
News | Coronavirus (COVID-19)

November 22, 2021 — Lung autopsy and plasma samples from people who died of COVID-19 have provided a clearer picture of ...

Time November 22, 2021
arrow
News | Lung Imaging

November 19, 2021 — Lung cancer screening is recommended only for those who are at high risk for the disease — adults ...

Time November 19, 2021
arrow
News | X-Ray

November 19, 2021 — “Data drive decisions and with the latest trial data, we are positioned for growth,” said Amol ...

Time November 19, 2021
arrow
News | Artificial Intelligence

November 18, 2021 — Worldwide the most common cause of cancer mortality in 2020 was lung cancer, with an estimated 1.80 ...

Time November 18, 2021
arrow
News | Artificial Intelligence

November 18, 2021 — VIDA Diagnostics Inc. (VIDA) is further removing friction in respiratory clinical trials with the ...

Time November 18, 2021
arrow
News | Lung Imaging

November 10, 2021 — According to an article in ARRS’ American Journal of Roentgenology (AJR), Lung-RADS — as applied by ...

Time November 10, 2021
arrow
Subscribe Now